The latest Constellation Brands stock analysis highlights the company’s struggles in fiscal 2026. Constellation Brands (NYSE:STZ), owner of popular beer brands like Corona and Modelo, issued weaker-than-expected guidance that sent its stock to pandemic-era lows. On Sept. 2, STZ fell 6.6% intraday before sliding another 3%, hitting a new 52-week low of $146.60.

CEO Bill Newlands pointed to slowing high-end beer sales, fewer consumer shopping trips, and reduced spending per visit. Elevated tariffs on imported beer have further squeezed margins, while cautious spending in core demographics, especially Hispanic consumers, has weighed heavily on results.

About STZ Stock

Constellation Brands, a Fortune 500 company headquartered in Rochester, New York, has a global presence spanning the U.S., Mexico, Italy, and New Zealand. Despite its scale, Constellation Brands stock analysis shows the company has lost significant market value in 2025. STZ is down 33.5% year-to-date and has plunged 40.5% over the past 52 weeks.

The company currently trades at 12.86 times forward non-GAAP earnings, a discount compared to both peers and historical averages. This valuation discount has caught the attention of value-focused investors, but questions remain about whether the weakness is temporary or structural.

Weak Quarterly Results Pressure Outlook

Constellation Brands reported first-quarter fiscal 2026 results on July 1. Revenue dropped 6% year-over-year to $2.5 billion, while comparable operating income fell 11%. Net income tumbled 41% to $516 million. EPS came in at $3.22, down 10% compared to the same quarter last year.

Breaking it down further, the beer segment posted a 2% decline in net sales, primarily from a 3.3% drop in shipment volumes. Meanwhile, the wine and spirits division reported a steep 28% sales decline on 30.4% lower shipments.

Adding to investor unease, management slashed fiscal 2026 guidance. Comparable EPS is now expected in the $11.30 to $11.60 range, down from prior guidance of $12.60 to $12.90. Revenue forecasts also worsened, with expected organic net sales to decline between 6% and 4%.

Beer sales, which drive the bulk of revenue, are projected to fall 4% to 2%. The wine and spirits business remains weak, with expected declines between 17% and 20%.

Analyst Reactions to STZ Stock

Wall Street analysts remain divided in their Constellation Brands stock analysis. Bank of America cut its price target to $142 while maintaining an “Underperform” rating, citing the difficult consumer backdrop. Jefferies, however, reduced its target from $205 to $179 but kept a “Buy” rating, noting that the recent weakness may already be priced in.

In total, STZ carries a consensus “Moderate Buy” rating. Out of 23 analysts, 10 recommend “Strong Buy,” three “Moderate Buy,” nine “Hold,” and one “Moderate Sell.” The average price target sits at $202.28, suggesting 38% upside potential, with a Street-high target of $239 implying as much as 63% upside from current levels.

Should You Buy Constellation Brands Stock?

Investors weighing whether to buy Constellation Brands stock must balance near-term headwinds with long-term opportunity. On the negative side, tariffs, weakening demand in premium beer, and broader economic pressures have created strong headwinds.

On the positive side, Constellation Brands stock analysis indicates that valuation is now more attractive, and the company’s iconic beer portfolio continues to hold long-term consumer appeal. Analysts expect EPS to rebound by 19% in fiscal 2027, rising to $13.62, suggesting that the current dip may be cyclical rather than permanent.

For investors willing to tolerate short-term volatility, Constellation Brands may represent a compelling opportunity. With shares at multi-year lows but analyst targets implying significant upside, Constellation Brands stock could reward patient investors who believe in the resilience of its core beer brands.

Featured Image: Freepik @ Racool_studio

Please See Disclaimer